Urban health in the context of poverty, inequity and polarization trends in developing countries. .Harpham T, Molyneux CS
Global Report on Human Settlements, UNCHS, (2001). :
Neuro-cognitive sequelae following falciparum malaria..Newton CRJC
Italian Journal of Tropical Medicine , (2001). 6:4-8
Clinical drug interaction .Kokwaro G
East African Medical Journal, (2001). 78:505-506
Medical research in Africa: problems and some solutions./kokwaro.Kokwaro G, Kariuki S
Malawi Med J, (2001). 13:40
Urban health in developing countries: a review.Harpham T, Molyneux C
Progress in Development Studies, (2001). 1:113-137
A new antiplasmodial coumarin from Toddalia asiatica roots.Oketch-Rabah HA, Mwangi JW, Lisgarten J, Mberu EK
Fitoterapia, (2000). 71:636-40
A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants.English M, MacLennan JM, Bowen-Morris JM, Deeks J, Boardman M, Brown K, Smith S, Buttery J, Clarke J, Quataert S, Lockhart S, Moxon ER
Vaccine, (2000). 19:1232-8
Risk and aetiology of diarrhoea at various tourist destinations.von Sonnenburg F, Tornieporth N, Waiyaki P, Lowe B, Peruski LF, DuPont HL, Mathewson JJ, Steffen R
Lancet, (2000). 356:133-4
Arginine vasopressin secretion in Kenyan children with severe malaria.Sowunmi A, Newton CR, Waruiru C, Lightman S, Dunger DB
J Trop Pediatr, (2000). 46:195-9
Paediatric survival and re-admission risks following hospitalization on the Kenyan coast.Snow RW, Howard SC, Mung'Ala-Odera V, English M, Molyneux CS, Waruiru C, Mwangi I, Roberts DJ, Donnelly CA, Marsh K
Trop Med Int Health, (2000). 5:377-83
The burden of malaria: understanding the balance between immunity, public health and control.Snow RW
J Med Microbiol, (2000). 49:1053-5
Using evidence to change antimalarial drug policy in Kenya.Shretta R, Omumbo J, Rapuoda B, Snow RW
Trop Med Int Health, (2000). 5:755-64
Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.Shretta R, Brugha R, Robb A, Snow RW
Lancet, (2000). 355:1718-20
Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands.Shanks GD, Biomndo K, Hay SI, Snow RW
Trans R Soc Trop Med Hyg, (2000). 94:253-5
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya.Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B, Mandaliya K, Getambu E, Gleeson F, Drobniewski F, Marsh K
Lancet, (2000). 355:1225-30
Validation of immune-complex enzyme immunoassays for diagnosis of pneumococcal pneumonia among adults in Kenya.Scott JA, Hall AJ, Leinonen M
Clin Diagn Lab Immunol, (2000). 7:64-7
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates.Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, Marsh K, Newbold CI, Atkinson JP, Miller LH
J Immunol, (2000). 165:6341-6
Autoagglutination of malaria-infected red blood cells and malaria severity.Roberts DJ, Pain A, Kai O, Kortok M, Marsh K
Lancet, (2000). 355:1427-8
Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes.Rawden HC, Kokwaro GO, Ward SA, Edwards G
Br J Clin Pharmacol, (2000). 49:313-22
Antibiotic susceptibility and genotypes of non-typhi Salmonella isolates from children in Kilifi on the Kenya coast.Oundo JO, Kariuki S, Maghenda JK, Lowe BS
Trans R Soc Trop Med Hyg, (2000). 94:212-5
